Forum Agenda
-
Medicine-Engineering Integration and Innovative Medical Devices
-
China’s Innovation Ecosystem and Models
-
Research Translation and Early-stage Project Incubation Meeting
-
Accelerating Innovation Through External Collaboration Meeting
-
Leveraging China's Innovation to Accelerate Global Drug R&D Meeting
-
USTC Original Innovation Power: Alumni Enterprise Innovation Matrix Meeting
-
Clinical Translation of Medical Research Achievements Meeting
-
Cross-Border Cooperation and China’s New Drug Global Expansion
-
Global Development of Pharma Enterprises and Emerging Market Cooperation
-
Legal Safeguard and Value Empowerment for Globalization of Chinese Pharma Enterprises
-
JunHe LLP Session:New Models of Cross-Border Pharmaceutical Cooperation Session
-
Protheragen Session: Global Biomedical Cross-Border Transactions
-
Advanced Stem Cell Culture Process Symposium
Stay tuned
Moderator:Shang Xiao,Founder & Chairman, Youyi Bio
Culture of MSC: from 2D to 3D, and beyond
Lianming Liao:CSO, Tuohong Bio
High-Efficiency Exosome Production Factory Driven by All-Factor Integrated Medium
Ali Mohsin:VP of R&D, Youyi Bio
Roundtable 1: Implementation of Documents No. 818 and No. 828 – Risks and Challenges in Cell Therapy Supply Chain under Dual Regulatory Frameworks
Yutian Shen: CEO, Saijun Bio
Zhiying He: Distinguished Researcher & Executive Director,Institute for Regenerative Medicine,Shanghai East Hospital of Tongji University
Yonghong Yin: Deputy GM, Sailiwei Bio
Yijie Yang: Co-founder & CEO, Shenzhen Huixin Bio-Medical Technology Co., Ltd.
Yueming Wang: CEO, Yuanxin Excellence Bio; International Advisor, Beijing Daxing International Airport Economic Zone
Ting Zhang: CEO, Gemrisen
Roundtable 2: Compliance and Prospects of MSC Cell Therapy
Wei Wu(Moderator): General Manager, Suzhou Youyi Bio
Chencai Liu: Deputy GM, Qichuang Research Institute
Lin Shi: Chief Medical Officer, Jinfeng Laboratory; former VP of Yuanda Medical; Vice Chairperson, CBIITA Consortium; Professor
Guanghua Yang: Chief Scientist, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Chairman, Heji (Shanghai) Medical Technology Co., Ltd.
Zhang Wenjun: Deputy Director, Institute of Hematology, Tongji University; Deputy Director, Oncology Center, Tongji Hospital; Deputy Director, Institute of Hematology, Tongji University School of Medicine
PAN SWEE TING: Managing Director & Head of China, JIF Capital